The one small observational study suggested modest additional benefit, but high-quality randomized trials are lacking
Suitable for dry or dull skin
May help avoid excessive hunger*
Navigating GLP-1 Medications and Plasma Donation The increasing prevalence of GLP-1 agonists like Ozempic (semaglutide), Mounjaro (tirzepatide), Zepbound (tirzepatide), and Wegovy (semaglutide) for managing Type 2 diabetes and supporting weight loss has naturally led to questions about their impact on plasma donation eligibility
Another important metabolism regulating enzyme activated by insulin receptor signaling is small ribosomal subunit protein 6 (p70) kinase, (p70S6K)
The maintenance study FIGARO UC 303 (NCT03290781) enrolled 366 responders who continued their induction dose or switched to placebo for 52 weeks, demonstrating that both 25mg and 75mg doses significantly outperformed placebo with clinical remission rates of 53.5% and 40.2% respectively versus approximately 8-13% placebo, while inclusion criteria required patients aged 1866 years with moderate to severe disease and the completed studies showed favorable safety profiles with most common adverse events being UC worsening, arthralgia, and nasopharyngitis (51)